Important EU Project

Important EU Project HORIZON-MISS-2022-CANCER-01

06/11/2025

IMPORTANT EU Project at the EU Health Policy Platform Live Webinar!
We are proud that Antonis Valachis, Coordinator of the IMPORTANT Project, participated as a panelist in Panel Session 1: Treatment and Optimisation during the EUHPP Live Webinar: Cancer Mission Diagnosis and Treatment (Refractory Cancers and Diagnostics) Cluster Policy Webinar, held on 3 November 2025.

The discussion focused on advancing cancer diagnosis and treatment across Europe — a mission that aligns closely with IMPORTANT’s goal to optimize and personalize breast cancer therapy for older patients through a pragmatic, decentralized clinical study conducted across six EU countries.

The IMPORTANT EU Project project was proud to be present at the ESMO - European Society for Medical Oncology) Congress 2...
31/10/2025

The IMPORTANT EU Project project was proud to be present at the ESMO - European Society for Medical Oncology) Congress 2025 in Berlin, where Prof. Laura Biganzoli presented the project during her talk on “Systemic treatment for aging patients” — part of the session “Optimising treatment for aging patients living with metastatic breast cancer” on Saturday, 18 October 2025.

Her presentation showcased the Implementation of geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients — the IMPORTANT trial, a pragmatic randomized-controlled study supported by the HORIZON-MISS-2022-CANCER-01 program (ClinicalTrials.gov ID: NCT06044623).

This work represents an important step toward improving treatment personalization and quality of life for older adults with advanced breast cancer, aligning with the broader mission of the IMPORTANT project to bring evidence-based geriatric assessment into clinical decision-making.

🌍 IMPORTANT Project at the Horizon Europe Cancer Mission Cluster 2nd Annual Meeting – Berlin 2025 🇩🇪On 16 October 2025, ...
29/10/2025

🌍 IMPORTANT Project at the Horizon Europe Cancer Mission Cluster 2nd Annual Meeting – Berlin 2025 🇩🇪

On 16 October 2025, the IMPORTANT Project proudly participated in the 2nd Annual Meeting of the Horizon Europe Cancer Mission “Diagnosis & Treatment” Cluster, held at the Charité University Hospital in Berlin, Germany.

This annual gathering brought together representatives from the 13 funded projects within the Mission Cancer Cluster to:

✔️ Present project progress and future plans,
✔️ Discuss cross-cutting topics such as data management, communication, citizen engagement, and inequalities,
✔️ Exchange best practices and generate material for upcoming policy briefs and joint cluster deliverables.

🗓️ Meeting Highlights
The full-day agenda included presentations and roundtables covering:
Project status updates and shared deliverables on Data Management, Communication and a Common Work Plan,
WG1: Collaborative Framework & Data Management
WG2: Dissemination and Communication of Results
WG3: Research and Innovation
WG4: Citizen Engagement
WG5: Addressing Inequalities

💬 IMPORTANT Project’s Contributions
During the meeting, Dr. Antonis Valachis (Örebro University) chaired the WG5 – Addressing Inequalities roundtable, highlighting how the project contributes to reducing disparities in cancer diagnosis and treatment access across Europe through evidence-based and patient-centered approaches.

In the WG4 – Citizen Engagement session, led by Carina Dantas (SHINE 2Europe), Kelly Mastoraki (Circular Economy Foundation) presented IMPORTANT’s recent actions at the European Researchers' Night’ 2025 in Nicosia, Cyprus, showcasing how the project connects science and society through creativity, empathy and collaboration, engaging citizens of all ages in meaningful dialogue about cancer prevention and research.

A huge thank-you to all our partners in the Diagnosis & Treatment Cluster and to the organisers (CARE1 Project) of this inspiring and collaborative meeting in Berlin. Together, we continue advancing a more inclusive, participatory and impactful European cancer research mission.
Together, we continue advancing a more inclusive, participatory and impactful European cancer research mission.

09/09/2025

We are delighted to announce that the paper with Maryam Rabie Yeganeh from University of Applied Sciences and Arts Northwestern Switzerland FHNW, has been presented at REWBAH'25 in Valencia, Spain, co-located with RE’25.

“One Size Doesn’t Fit All”: Patient Support in a Decentralised Clinical Trial
This research explores how patient support in decentralized clinical trials can be better adapted to diverse needs — a key step toward more inclusive and effective digital health solutions.

A special thanks to our project partner FHNW for their contributions and support and to the REWBAH community for the fruitful exchange.


Adress

Örebro

Aviseringar

Var den första att veta och låt oss skicka ett mail när Important EU Project postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Dela

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram